Boehringer expands neurology activities
Boehringer Ingelheim has expanded its 2014 R&D collaboration with the BioMed X Innovation Center (Heidelberg, Germany) to find new treatment approaches for early intervention of psychiatric diseases.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2155 entries already.
Entries by Thomas Gabrielczyk
New target for lung fibrosis discovered
Canadian and Finnish researchers have demonstrated that long immune cell contact to lung tissue turns tissue repair into fibrosis.
Valneva inks $59m JE vaccine supply contract
French vaccine specialist Valneva SE has inked a supply contract with the US Department of Defense for IXIARO its Japanese encephalitis (JE).
VTT turn waste into biofuels and chemicals
Researchers at VTT Technical Research Centre of Finland Ltd have presented a new gasification-based technique to turn forest industry byproducts into transport fuels and chemicals.
Tissue specific tumour transition needs few cells
German researchers have modeled when cellular alterations inevitably lead to the development of cancer. The transition is tissue-specific and needs only a few cells.
Highest manufacturing standard: First Line
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our unique product range includes the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. These are based on a broad spectrum of experience in the healthcare industry. To ensure the highest quality in our broad product portfolio, we have implemented the most advanced manufacturing standard.
Drug dissociates metastasis precursors in blood
A team of Swiss researchers has identified Na+/K+-ATPase blockers as candidate drugs capable to prevent formation of metastases. In blood, the repurposed drugs identified in a screening dissociated clusters of circulating tumour cells (CTCs), forerunners of metastases.
Policymakers take no action after ECJ mutagenesis ruling
In summer the European Court of Justice (ECJ) ruled that crops created by biological mutagenesis techniques fall under EU GMO legislation. Germany’s government and the European Parliament see no need to take action.
Sandoz’ antiinfectives partner Ares Genetics gets fund
Just in mid-December, antibiotic resistance detection expert Ares Genetics (Vienna, Austria) inked an agreement with Sandoz to use its pathogenome database and bio-IT know-how to develop repurposed and novel antiinfectives that help fight antimicrobial resistance (AMR). Now, the company baged another financing to expand its diagnostic capabilities.
AI provides face read-out of genetic diseases
Experts in artificial intelligence (AI) have created another problem for bioethicists and data protection specialists: their algorithm has learned to identify people with rare genetic syndromes from facial images.